18 February 2021

Recent advances in DNA sequencing technologies have made it possible to uncover the causes of multiple rare diseases. A study co-directed by Alexandre Reymond (University of Lausanne), Simon Fisher (Max Planck Institute for Psycholinguistics) and Lisenka Vissers (Radboudumc) published online January 28, 2021 by The American Journal of Human Genetics describes how three classes of mutation within the same gene result in different neurodevelopmental disorders.

An international network of geneticists

The identification of causal variants in rare genetic diseases has been facilitated by the advent of high-throughput sequencing technologies. “We can now precisely define the region of the genome associated with a disease”, says study co-leader Lisenka Vissers from Radboud University, Nijmegen, The Netherlands.

A collaborative effort that brings together geneticists and clinicians from twelve countries on four continents allowed identification of 42 patients with mutations in a gene named SATB1. It encodes the information to produce a protein that can bind DNA and diminish the expression of other genes.

Three classes of mutation

The DNA variants found in the genome of these patients belong to three different classes. “We could investigate the impacts of each distinct type of mutation in human cells that we grow in the lab” notes study co-leader Simon Fisher from the Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands. The first class of mutations, identified in eight patients, encompasses DNA variants that destroy the function of the SATB1 gene and halve the production of the encoded protein. The second contains four mutations, which encode shorter proteins that are less efficient as they are not located correctly in the cell. The third class encompasses the mutations found in the last thirty patients. These mutations modify the encoded protein making it more active. This altered protein is “sticky” and binds better to DNA, thus diminishing the expression of genes it regulates.

Different symptoms

The geneticists uncovered that these three modes of action were associated to different neurodevelopmental disorders. The proteins that are functioning "too well" cause a severe intellectual disability often associated with epilepsy, a motor speech disorder and distinctive facial features. The lack of protein is associated with reduced cognitive functions (but less severe) and visual problems. The patients with mutations that produce shorter and mislocalised proteins show an intermediate syndrome.

Beyond sequencing

These results demonstrate that each mutation is different and that it is essential to understand their modes of action to elucidate the origin of genetic diseases. “We must go beyond DNA sequencing, which is only a first step”, concludes study co-leader Alexandre Reymond, University of Lausanne, Switzerland.

Contacts:

Alexandre Reymond, alexandre.reymond@unil.ch

Simon Fisher, Simon.Fisher@mpi.nl

Lisenka Vissers, Lisenka.Vissers@radboudumc.nl

Related news items


New way of diagnostics detects 'undetectable' genetic defects

15 April 2021

Research provides guidance for global application

read more

Vici grant for Michiel Vermeulen Reading the epitranscriptome

15 April 2021

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

COVID-19 regulations for nursing homes have varying effects

14 April 2021

On May 11th 2020, the Dutch Government allowed 26 nursing homes to welcome one visitor per resident, after two months of lockdown. An in-depth Radboudumc study monitored the feasibility of the regulations and the impact on the well-being of residents, their visitors, and healthcare staff.

read more

Anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity

14 April 2021

Cell reports publication by Charles Dinarello and Mihai Netea and colleagues, theme Infectious diseases and global health, shows that the anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.

read more

ADHD-related alterations in brain organization based on different brain profiles

14 April 2021

Structural differences between the brains of people with and without ADHD are extensively reported. In accordance with earlier (ENIGMA) studies, and using a large cohort, a newly published study builds upon these by showing differences in brain organization that is based on different brain profiles.

read more